You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
远大医药(00512.HK):全球创新药STC3141获准进入Ib期临床研究
阿思达克 03-03 17:51
远大医药(00512.HK)公布,全资附属Grand Medical Pty Ltd正在开发的用於治疗脓毒症的全球创新药物STC3141於去年12月向国家药品监督管理局(NMPA)递交新药临床试验申请(IND)并获得受理以来,於近日取得NMPA核准签发之「药物临床试验批准通知书」,获得批准在另一适应症急性呼吸窘迫综合症(ARDS)中开展Ib期临床研究。

公司指,将重点评估药物在ARDS患者中的的安全性、耐受性和代谢特性,积累更多资料综合评估後期临床试验的风险和获益,以加快产品的全球开发进程。

网址:www.aastocks.com

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account